A feedforward loop between STAT1 and YAP1 stimulates lipid biosynthesis, accelerates tumor growth, and promotes chemotherapy resistance in mutant KRAS colorectal cancer
Open Access
- 25 August 2025
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-16
Abstract
In tumorous conditions, STAT1, traditionally recognized for its anti-tumor role in immunology, exhibits pro-survival characteristics, though unclear mechanisms. Investigating STAT1 function in isogenic colorectal tumor cells with wild-type or mutant KRAS, we found that STAT1 specifically promotes tumor survival and proliferation with mutant KRAS. Gene expression profiling revealed that STAT1 promotes the expression of sterol and lipid biosynthesis genes in these cells. This effect depends on STAT1 phosphorylation at S727, which upregulates SREBP1 and SREBP2 to drive de novo lipid production. In mutant KRAS cells, STAT1 amplifies the mevalonate pathway, maintaining its S727 phosphorylation and establishing a positive feedback loop through the transcription factors YAP1 and TEAD4, further driving lipid biosynthesis and tumor growth. This STAT1-YAP1 axis promotes mutant KRAS tumor cells’ resistance to mevalonate pathway inhibitors, which can be overcome by pharmacologically targeting the YAP1-TEAD interaction. Moreover, this axis contributes to the inherent resistance of mutant KRAS colon cancer cells to EGFR-targeted therapy. Together, these findings identify the STAT1-YAP1 pathway as a critical mediator of therapy resistance and a promising therapeutic target in mutant KRAS colorectal cancer.Keywords
All Related Versions
Funding Information
- Gouvernement du Canada | Canadian Institutes of Health Research (PJT-178173)
- Canadian Cancer Society Research Institute (CCSRI #701631)
This publication has 79 references indexed in Scilit:
- AZD8055 enhances in vivo efficacy of afatinib in chordomasThe Journal of Pathology, 2021
- Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal CancerCancer Cell, 2018
- RAS Proteins and Their Regulators in Human DiseaseCell, 2017
- How Low Cholesterol Is Good for Anti-viral ImmunityCell, 2015
- Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN SignalingCell, 2015
- KRAS and YAP1 Converge to Regulate EMT and Tumor SurvivalCell, 2014
- Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic CancerCell, 2014
- Differences in antitumor effects of various statins on human pancreatic cancerInternational Journal of Cancer, 2007
- Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBPCell, 2005
- Sterol Regulatory Element-Binding Protein-1 Participates in the Regulation of Fatty Acid Synthase Expression in Colorectal NeoplasiaExperimental Cell Research, 2000